Effects of vitamin D and retinoic acid on human glioblastoma cell lines
Authors:
- 1 September 1995
- journal article
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 133 (3-4) , 184-190
Abstract
The biological significance of vitamin D receptors expressed by glioblastoma and other glial tumours is still unclear. In an effort to clarify this issue we studied the effects of increasing concentrations of 25-dihydroxyvitamin D3 and its metabolite 1 α, 25-dihydroxyvitamin D3 on two human glioblastoma cell lines. Both substances were capable of inducing a significant (> 50%) reduction in growth of the two glioblastoma cell lines at dosages over 5 μM. When the HU 70 cell line was treated by increasing dilutions of 25-dihydroxyvitamin D3 combined with 1 μM all trans-retinoic acid, significant inhibition was apparent even after addition of 25-dihydroxyvitamin D3 in the nanomolar range. Reduction of growth index was mainly due to induced cell death. Our results providein vitro evidence that vitamin D metabolites alone or in combination with retinoids may be potentially useful agents in the differentiation therapy of human malignant gliomas.Keywords
This publication has 40 references indexed in Scilit:
- Subcellular localization and partial purification of the 25-hydroxyvitamin D3 1-hydroxylation reaction in the chick myelomonocytic cell line HD-11Journal of Bone and Mineral Research, 1993
- Synthesis of active metabolite(s) from 1α‐hydroxyvitamin D3 by human monocytic leukemia cellsFEBS Letters, 1992
- 25-Hydroxyvitamin D3 Metabolism in vitro by Mononuclear Cells from Hemodialysis PatientsNephron, 1992
- The Relationship between Survival and the Extent of the Resection in Patients with Supratentorial Malignant GliomasNeurosurgery, 1991
- The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomasNeurosurgery, 1991
- Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Topical calcipotriol treatment in advanced breast cancerThe Lancet, 1991
- Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisThe Lancet, 1991
- Overexpression of N-ras Oncogene and Epidermal Growth Factor Receptor Gene in Human GlioblastomasJNCI: Journal of the National Cancer Institute, 1989
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981